Diartis Pharmaceuticals Receives New Financing Round

  • Feed Type
  • Date
  • Company Name
    Diartis Pharmaceuticals
  • Mailing Address
    500 Ellis St. Mountain View, CA 94043
  • Company Description
    Diartis is a biotechnology company founded to develop therapeutics for the treatment of metabolic diseases that address both significant unmet medical needs as well as large market opportunities.
  • Website
  • Transaction Type
    Venture Equity
  • Transaction Amount
  • Transaction Round
  • Proceeds Purposes
    The company will focus on moving this exciting compound rapidly through early clinical development. Given the dramatic rise in the number of people with type 2 diabetes, there is a significant market need for a longer acting form of the GLP-1 analog exenatide.
  • M&A Terms
  • Venture Investor
    Index Ventures
  • Venture Investor

Trending on Xconomy